
Thrilled to share latest work: Fine-tuning BACH2 dosage balances stemness and effector function to enhance antitumor T cell therapy - now online in Nature Immunology. @alberto_g_conti, Alex Evans, @teresavlinde, @IanParish_AU, @cdtdeg @CRUKCamCentre nature.com/articles/s41590-0…



























